RedHill Biopharma RDHL Price Prediction

The determination to procure RedHill Biopharma is entirely contingent on your individualistic risk tolerance. As you may discern, RedHill Biopharma's value has experienced a fall of -5.5% during the preceding 24 hours, and RedHill Biopharma has incurred a decline of -4.63% over the prior 30-day duration. Consequently, the determination of whether or not to invest in RedHill Biopharma will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of RedHill Biopharma may potentially surge to $1.41 by the end of this year. Looking at RedHill Biopharma's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $1.35. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental RedHill Biopharma forecast, the price of RedHill Biopharma will fall by -1.86% over the next week and reach $1.01 by January 24, 2026.

Based on the our new experimental RedHill Biopharma forecast, the price of RedHill Biopharma will increase by 4.33% over the next month and reach $1.07 by February 16, 2026.

As per our most recent prediction on RedHill Biopharma's value in 2026, RDHL is anticipated to fluctuate within the range of $1.00 and $1.41. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected RedHill Biopharma price forecast fails to consider sudden and extreme price fluctuations.

RedHill Biopharma's future appears to be on an upward trend, with an maximum price of $1.35 projected after a period of five years. Based on the RedHill Biopharma forecast for 2031, RedHill Biopharma's value may potentially reach its highest peak of approximately $1.35, while its lowest peak is anticipated to be around $1.19.

Based on the our new experimental RedHill Biopharma price prediction simulation, RDHL’s value in 2026 expected to grow by 37.19% to $1.41 if the best happened. The price will be between $1.41 and $1.00 during 2026.

According to our latest experimental simulation for RedHill Biopharma price prediction, RDHL’s value could rise by 45.07% to $1.49 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $1.49 and $1.11 throughout the year.

Our new experimental RedHill Biopharma price prediction model suggests that RDHL’s value in 2028 could increase by 16.66% , reaching $1.20 in the best-case scenario. The price is expected to range between $1.20 and $0.85 during the year.

Based on our experimental forecast model, RedHill Biopharma's value may experience a 3.26% growth in 2029, potentially reaching $1.06 under optimal conditions. The predicted price range for 2029 lies between $1.06 and $0.87.

Using our new experimental simulation for RedHill Biopharma price predictions, RDHL’s value in 2030 is expected to rise by 26.18% , reaching $1.29 in the best scenario. The price is forecasted to range between $1.29 and $0.92 over the course of 2030.

Our experimental simulation indicates that RedHill Biopharma’s price could grow by 31.42% in 2031, potentially hitting $1.35 under ideal conditions. The price will likely fluctuate between $1.35 and $1.19 during the year.

Based on the findings from our latest experimental RedHill Biopharma price prediction, RDHL could see a 62.58% rise in value, reaching $1.67 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $1.67 and $1.31 throughout the year.

According to our experimental RedHill Biopharma price prediction, RDHL’s value is anticipated to rise by 117.02% in 2033, with the highest potential price being $2.23. Throughout the year, RDHL’s price could range from $2.23 and $1.67.

The results from our new RedHill Biopharma price prediction simulation suggest that RDHL may rise by 156.62% in 2034, potentially reaching $2.64 under the best circumstances. The predicted price range for the year is between $2.64 and $2.15.

Based on our experimental forecast for RedHill Biopharma’s price, RDHL could grow by 233.55% , with the value potentially hitting $3.43 in 2035. The expected price range for the year lies between $3.43 and $2.46.

Our recent RedHill Biopharma price prediction simulation suggests that RDHL’s value might rise by 382.69% in 2036, possibly reaching $4.97 if conditions are optimal. The expected price range for 2036 is between $4.97 and $3.24.

According to the experimental simulation, RedHill Biopharma’s value could rise by 543.2% in 2037, with a high of $6.62 under favorable conditions. The price is expected to fall between $6.62 and $4.86 over the course of the year.